Risk factors for ventricular arrhythmias after emergency percutaneous coronary intervention in elderly patients with acute myocardial infarction
- PMID: 38883350
- PMCID: PMC11170566
- DOI: 10.62347/WZNF8280
Risk factors for ventricular arrhythmias after emergency percutaneous coronary intervention in elderly patients with acute myocardial infarction
Abstract
Objective: To explore the risk factors for ventricular arrhythmia after percutaneous coronary intervention (PCI) in elderly patients with acute myocardial infarction (AMI).
Methods: A retrospective cohort of 201 elderly AMI patients who underwent PCI in the emergency department of No. 215 Hospital of Shaanxi Nuclear Industry from April 2020 to January 2023 was analyzed. The patients were randomly divided into a training set (n=134) for model development and a test set (n=67) for model validation. The training set was divided into a ventricular arrhythmia group (n=51) and a non-ventricular arrhythmia group (n=83), based on the occurrence of ventricular arrhythmia post-PCI. The factors affecting ventricular arrhythmias were analyzed by logistic regression and Lasso regression models.
Results: Lasso regression screened 12 characteristic factors at λ=0.1 se. In the training set, the area under the ROC curve (AUC) of the Lasso model for predicting ventricular arrhythmia was 0.954, which was significantly higher than 0.826 for the Logistic model (P < 0.001). In the test set, the AUC of the Lasso model was 0.962, which was also significantly higher than 0.825 for the Logistic model (P=0.003).
Conclusion: Compared to the logistic regression model, the Lasso regression model can more accurately predict the occurrence of ventricular arrhythmia after PCI in elderly AMI patients. The Lasso regression model constructed in this study can provide a reference for the clinical identification of high-risk elderly AMI patients and the development of targeted monitoring and treatment.
Keywords: Acute myocardial infarction; percutaneous coronary intervention; risk factors; ventricular arrhythmia.
AJTR Copyright © 2024.
Conflict of interest statement
None.
Figures




Similar articles
-
Construction and validation of nomogram model for predicting the risk of ventricular arrhythmia after emergency PCI in patients with acute myocardial infarction.Aging (Albany NY). 2024 May 10;16(9):8246-8259. doi: 10.18632/aging.205815. Epub 2024 May 10. Aging (Albany NY). 2024. PMID: 38742959 Free PMC article.
-
Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.Front Cardiovasc Med. 2022 Dec 21;9:1050785. doi: 10.3389/fcvm.2022.1050785. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36620648 Free PMC article.
-
[Predictive value of hemoglobin to serum creatinine ratio combined with serum uric acid for in-hospital mortality after emergency percutaneous coronary intervention in patients with acute myocardial infarction].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Sep;35(9):951-957. doi: 10.3760/cma.j.cn121430-20230418-00291. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37803954 Chinese.
-
A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.Clin Interv Aging. 2023 Mar 22;18:453-465. doi: 10.2147/CIA.S402408. eCollection 2023. Clin Interv Aging. 2023. PMID: 36987461 Free PMC article. Clinical Trial.
-
The impact of the time factors on the exercise-based cardiac rehabilitation outcomes of the patients with acute myocardial infarction after percutaneous coronary intervention: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2024 Jan 6;24(1):35. doi: 10.1186/s12872-023-03692-z. BMC Cardiovasc Disord. 2024. PMID: 38184523 Free PMC article.
Cited by
-
Development and Validation of a Nomogram to Predict Ventricular Fibrillation During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.Rev Cardiovasc Med. 2025 Jul 22;26(7):37301. doi: 10.31083/RCM37301. eCollection 2025 Jul. Rev Cardiovasc Med. 2025. PMID: 40776936 Free PMC article.
References
-
- Buiten RA, Ploumen EH. Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate. Lancet. 2023;402:1942–1943. - PubMed
-
- Jollis JG, Granger CB, Zegre-Hemsey JK, Henry TD, Goyal A, Tamis-Holland JE, Roettig ML, Ali MJ, French WJ, Poudel R, Zhao J, Stone RH, Jacobs AK. Treatment time and in-hospital mortality among patients with ST-segment elevation myocardial infarction, 2018-2021. JAMA. 2022;328:2033–2040. - PMC - PubMed
-
- Li Y, Liang Z, Qin L, Wang M, Wang X, Zhang H, Liu Y, Li Y, Jia Z, Liu L, Zhang H, Luo J, Dong S, Guo J, Zhu H, Li S, Zheng H, Liu L, Wu Y, Zhong Y, Qiu M, Han Y, Stone GW. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial. Lancet. 2022;400:1847–1857. - PubMed
-
- Pu J, Ding S, Ge H, Han Y, Guo J, Lin R, Su X, Zhang H, Chen L, He B EARLY-MYO Investigators. Efficacy and safety of a pharmaco-invasive strategy with half-dose alteplase versus primary angioplasty in ST-segment-elevation myocardial infarction: EARLY-MYO trial (early routine catheterization after alteplase fibrinolysis versus primary PCI in acute ST-segment-elevation myocardial infarction) Circulation. 2017;136:1462–1473. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous